GB9523267D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9523267D0
GB9523267D0 GBGB9523267.4A GB9523267A GB9523267D0 GB 9523267 D0 GB9523267 D0 GB 9523267D0 GB 9523267 A GB9523267 A GB 9523267A GB 9523267 D0 GB9523267 D0 GB 9523267D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9523267.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GBGB9523267.4A priority Critical patent/GB9523267D0/en
Publication of GB9523267D0 publication Critical patent/GB9523267D0/en
Priority to PE1996000810A priority patent/PE17598A1/es
Priority to SK639-98A priority patent/SK63998A3/sk
Priority to TR1998/00851T priority patent/TR199800851T2/xx
Priority to PL96326636A priority patent/PL326636A1/xx
Priority to CN96198305A priority patent/CN1202170A/zh
Priority to CO96059775A priority patent/CO4770973A1/es
Priority to HU9903492A priority patent/HUP9903492A3/hu
Priority to CZ981494A priority patent/CZ149498A3/cs
Priority to AU75709/96A priority patent/AU7570996A/en
Priority to BR9611504A priority patent/BR9611504A/pt
Priority to JP9515313A priority patent/JPH11515000A/ja
Priority to EP96938196A priority patent/EP0873338A1/fr
Priority to CA002235126A priority patent/CA2235126A1/fr
Priority to PCT/EP1996/004978 priority patent/WO1997018208A1/fr
Priority to KR1019980703597A priority patent/KR19990067574A/ko
Priority to MX9803839A priority patent/MX9803839A/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9523267.4A 1995-11-14 1995-11-14 Organic compounds Pending GB9523267D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9523267.4A GB9523267D0 (en) 1995-11-14 1995-11-14 Organic compounds
PE1996000810A PE17598A1 (es) 1995-11-14 1996-11-12 Quinolinas
KR1019980703597A KR19990067574A (ko) 1995-11-14 1996-11-13 유형 ⅳ 포스포디에스테라제 억제제로서의 퀴놀린 유도체
CZ981494A CZ149498A3 (cs) 1995-11-14 1996-11-13 Deriváty chinolinu, způsob jejich přípravy, farmaceutický prostředek, který je obsahuje, a jejich použití
AU75709/96A AU7570996A (en) 1995-11-14 1996-11-13 Quinoline derivatives as type iv phosphodiesterase inhibitors
PL96326636A PL326636A1 (en) 1995-11-14 1996-11-13 Derivatives of quinoline as inhibitors of type iv phosphodiesterase
CN96198305A CN1202170A (zh) 1995-11-14 1996-11-13 用作iv型磷酸二酯酶抑制剂的喹啉衍生物
CO96059775A CO4770973A1 (es) 1995-11-14 1996-11-13 Quinolinas
HU9903492A HUP9903492A3 (en) 1995-11-14 1996-11-13 Quinoline derivatives as type iv phosphodiesterase inhibitors, process for their preparation, pharmaceutical compositions containing the same and their use
SK639-98A SK63998A3 (en) 1995-11-14 1996-11-13 Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use
TR1998/00851T TR199800851T2 (xx) 1995-11-14 1996-11-13 Tip IV fosfodiesteraz �nleyiciler olarak kullan�lan kinolin t�revleri.
BR9611504A BR9611504A (pt) 1995-11-14 1996-11-13 Derivados de quinolina como inibidores de fosfodiesterase do tipo iv
JP9515313A JPH11515000A (ja) 1995-11-14 1996-11-13 ▲ｉｖ▼４型ホスホジエステラーゼ阻害剤としてのキノリン導誘体
EP96938196A EP0873338A1 (fr) 1995-11-14 1996-11-13 Derives quinolines en tant qu'inhibiteurs des phosphodiesterases de type iv
CA002235126A CA2235126A1 (fr) 1995-11-14 1996-11-13 Derives quinolines en tant qu'inhibiteurs des phosphodiesterases de type iv
PCT/EP1996/004978 WO1997018208A1 (fr) 1995-11-14 1996-11-13 Derives quinolines en tant qu'inhibiteurs des phosphodiesterases de type iv
MX9803839A MX9803839A (es) 1995-11-14 1998-05-14 Derivados de quinolina como inhibidores de fosfodiesterasa tipo iv.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9523267.4A GB9523267D0 (en) 1995-11-14 1995-11-14 Organic compounds

Publications (1)

Publication Number Publication Date
GB9523267D0 true GB9523267D0 (en) 1996-01-17

Family

ID=10783856

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9523267.4A Pending GB9523267D0 (en) 1995-11-14 1995-11-14 Organic compounds

Country Status (17)

Country Link
EP (1) EP0873338A1 (fr)
JP (1) JPH11515000A (fr)
KR (1) KR19990067574A (fr)
CN (1) CN1202170A (fr)
AU (1) AU7570996A (fr)
BR (1) BR9611504A (fr)
CA (1) CA2235126A1 (fr)
CO (1) CO4770973A1 (fr)
CZ (1) CZ149498A3 (fr)
GB (1) GB9523267D0 (fr)
HU (1) HUP9903492A3 (fr)
MX (1) MX9803839A (fr)
PE (1) PE17598A1 (fr)
PL (1) PL326636A1 (fr)
SK (1) SK63998A3 (fr)
TR (1) TR199800851T2 (fr)
WO (1) WO1997018208A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100701904B1 (ko) 1999-08-21 2007-04-02 알타나 파마 아게 Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
CN1520313A (zh) 2001-05-23 2004-08-11 ������ҩ��ʽ���� 一种加速骨折愈合的组合物
CA2447618A1 (fr) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Composition pour le traitement regeneratif de la maladie du cartilage
TW200536851A (en) * 2004-01-23 2005-11-16 Amgen Inc Compounds and methods of use
JP2006347936A (ja) * 2005-06-15 2006-12-28 Bayer Cropscience Ag 殺虫性ベンズアニリド類
AR081377A1 (es) 2010-05-10 2012-08-29 Gilead Sciences Inc Compuestos de pirazolopiridina bifuncionales
EP2569285A1 (fr) 2010-05-10 2013-03-20 Gilead Sciences, Inc. Dérivés quinoliniques bifonctionnels
AR093017A1 (es) 2012-10-16 2015-05-13 Janssen Pharmaceutica Nv MODULARES DE RORgT DE QUINOLINILO UNIDOS POR METILENO
JP6250686B2 (ja) 2012-10-16 2017-12-20 ヤンセン ファーマシューティカ エヌ．ベー． Ｒｏｒγｔのヘテロアリール結合させたキノリニルモジュレータ
JP6251277B2 (ja) 2012-10-16 2017-12-20 ヤンセン ファーマシューティカ エヌ．ベー． ＲＯＲ−ガンマ−ｔのフェニル結合キノリニルモジュレーター
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
ES2770727T3 (es) 2013-10-15 2020-07-02 Janssen Pharmaceutica Nv Moduladores de quinilonila enlazados a alquilo de ROR(gamma)t
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9624225B2 (en) 2013-10-15 2017-04-18 Janssen Pharmaceutica Nv Quinolinyl modulators of RORγt
EP3813532B1 (fr) * 2018-06-24 2024-02-28 Adama Agan Ltd. Procédé de préparation de quinmérac

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines

Also Published As

Publication number Publication date
MX9803839A (es) 1998-09-30
KR19990067574A (ko) 1999-08-25
CZ149498A3 (cs) 1998-08-12
CA2235126A1 (fr) 1997-05-22
WO1997018208A1 (fr) 1997-05-22
AU7570996A (en) 1997-06-05
CO4770973A1 (es) 1999-04-30
SK63998A3 (en) 1998-10-07
HUP9903492A3 (en) 2000-08-28
PL326636A1 (en) 1998-10-12
EP0873338A1 (fr) 1998-10-28
CN1202170A (zh) 1998-12-16
PE17598A1 (es) 1998-04-06
TR199800851T2 (xx) 1998-08-21
JPH11515000A (ja) 1999-12-21
BR9611504A (pt) 1999-03-02
HUP9903492A2 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
GB9523267D0 (en) Organic compounds
GB9509156D0 (en) Organic compounds
GB9510477D0 (en) Organic compounds
GB9511486D0 (en) Organic compounds
GB9509159D0 (en) Organic compounds
GB9506176D0 (en) Organic compounds
GB9507479D0 (en) Organic compounds
GB9500086D0 (en) Organic compounds
GB9512958D0 (en) Organic compounds
GB9501035D0 (en) Organic compounds
GB9501036D0 (en) Organic compounds
GB9501038D0 (en) Organic compounds
GB9501155D0 (en) Organic compounds
GB9502121D0 (en) Organic compounds
GB9502771D0 (en) Organic compounds
GB9503092D0 (en) Organic compounds
GB9503553D0 (en) Organic compounds
GB9503950D0 (en) Organic compounds
GB9504073D0 (en) Organic compounds
GB9504287D0 (en) Organic compounds
GB9504332D0 (en) Organic compounds
GB9505080D0 (en) Organic compounds
GB9511704D0 (en) Organic compounds
GB9505860D0 (en) Organic Compounds
GB9504074D0 (en) Organic compounds